Transcriptomics Market Size Forecasted To Achieve 9.65 Billion By 2029 With Steady Growth

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Transcriptomics Market Size and Projected Growth Rate?
In recent years, there has been robust growth in the size of the transcriptomics market. The market, which was worth $6.51 billion in 2024, is forecasted to expand to $7.06 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.5%. The historic growth of the market can be linked to various factors such as the rising emphasis on personalized medicine, an increased incidence of cancer, the use of genomics in clinical diagnostics, the advancement of ribonucleic acid sequencing, and the increasing demand for biomarker discovery.

In the upcoming years, the transcriptomics market is set to experience robust growth. The market is projected to increase to $9.65 billion by 2029, with a compound annual growth rate (CAGR) of 8.1%. This growth during the forecast period can be tied to factors such as the escalating use of single-cell ribonucleic acid sequencing, an increase in the incorporation of spatial transcriptomics, surging demand for multiomics methods, a significant emphasis on early disease prognosis, and expanding knowledge about the role of non-coding ribonucleic acids. The forecast period is anticipated to see trends such as advancements in next-generation sequencing (NGS) technologies, progress in spatial transcriptomics technology, developments in bioinformatics tools, the application of machine learning in transcriptomics, and technology advancements in instantaneous transcriptomic analysis.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24417&type=smp

What Are the Major Segments in the Transcriptomics Market?
The transcriptomics market covered in this report is segmented -

1) By Type: Instruments, Consumables, Software, Services
2) By Technology: Micro Array, Real-Time Quantitative Polymerase Chain Reaction, Sequencing Technologies
3) By Application: Diagnostics And Disease Profiling, Drug Discovery, Other Applications
4) By End-User: Academic And Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Other End-Users

Subsegments:
1) By Instruments: Microarray Instruments, Sequencing Instruments, Polymerase Chain Reaction (PCR) Instruments, Other Transcriptomics Instruments
2) By Consumables: Reagents, Probes, Kits, Chips
3) By Software: Data Analysis Software: Data Management Software, Visualization Software: Bioinformatics Software
4) By Services: Data Analysis Services, Sample Preparation Services, Sequencing Services, Consulting Services

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24417&type=smp

What Are The Driving Transcriptomics Market Evolution?
The growth of the transcriptomics market is anticipated to be fueled by the escalating uptake of personalized medicine. This particular medical strategy tailors treatment to an individual's genetic makeup, lifestyle, and environment. Advancements in genetic sequencing have led to the expansion of personalized medicine, as it enables treatment to be adjusted according to a person's distinct genetic profile for improved efficacy. Transcriptomics helps in revealing individual gene expression patterns, which paves the way for tailored treatments founded on a patient's distinctive biology. This not only heightens the efficacy of treatment but also reduces side effects and aids in early disease identification. For example, as cited by the Personalized Medicine Coalition, a health care institution based in the US, the FDA issued approval for 16 novel personalized treatments catered to rare disease patients in the year 2023, a considerable increase from the six treatments approved in 2022. Consequently, the growing acceptance of personalized medicine is propelling the transcriptomics market's expansion.

Which Firms Dominate The Transcriptomics Market Segments?
Major companies operating in the transcriptomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Genewiz Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Singleron Biotechnologies, SCIEX, CD Genomics Inc., Parse Biosciences Inc., Lexogen GmbH, LC Sciences LLC, Arraystar Inc.

What Transcriptomics Market Trends Are Gaining Traction Across Different Segments?
Leading corporations in the transcriptomics market are concentrating on the innovation of superior products like single-cell spatial panels, to provide a profound understanding of cellular functions and disease processes. These panels not only study gene expression at the level of individual cells, but they also preserve each cell's location within the tissue. This combination of single-cell transcriptomics and spatial data provides valuable insights into cellular behaviour and tissue structure. As an example, NanoString Technologies, a biotechnology firm in the US, rolled out the CosMx 6,000 plex RNA Assay, a spatial molecular imaging assay, in February 2024. The rollout indicated the first time a single-cell spatial panel capable of assessing over 6,000 RNA targets across almost all human biological pathways became commercially available. The key thing about this innovation is that it's designed to work with the CosMx Spatial Molecular Imager (SMI), offering researchers the chance to profile genes at a single-cell and subcellular level with high precision and improved cell segmentation.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/transcriptomics-global-market-report

Which Is The Largest Region In The Transcriptomics Market?
North America was the largest region in the transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Transcriptomics Market?
2. What is the CAGR expected in the Transcriptomics Market?
3. What Are the Key Innovations Transforming the Transcriptomics Industry?
4. Which Region Is Leading the Transcriptomics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.